期刊文献+

中枢神经系统损害为首发症状的系统性红斑狼疮临床分析 被引量:4

Central nervous system impairment as an initial manifestation of patients with systemic lupus erythematosus
下载PDF
导出
摘要 目的探讨中枢神经系统(CNS)损害为首发症状的系统性红斑狼疮(SLE)的临床特征。方法回顾性分析10例首发CNS损害的SLE患者,分析其临床表现、影像学特征和治疗转归情况。结果 10例患者首发症状均为神经系统病变,临床表现包括头痛6例(60.0%)、癫痫5例(50.0%)、发热4例(40.0%)、脑梗死2例(20.0%)、静脉窦血栓2例(20.0%)、颅内多发病灶3例(30.0%)、脑干及脊髓病变2例(20.0%)、周围神经病变1例(10.0%)。神经精神性SLE的临床表现以头痛和癫痫发作出现概率最高。神经精神性SLE的脑部损害在MRI表现为弥漫型和局灶型病变,白质和灰质均可受累,分布无规律性。给予激素治疗后临床症状改善。结论 NPSLE临床表现多样,早期诊断、及时治疗是改善NPSLE预后的关键。 Objective To investigate the clinical features of central nervous system impairment as an initial manifestation in patients with systemic lupus erythematosus(SLE). Methods Ten cases of SLE with central nervous system impairment as an initial manifestation were reviewed. The clinical manifestations, imaging, treatment methods and results were analyzed. Results Central nervous system impairments were initial manifestations of all ten patients. Clinical manifestations included headache ( 60.0 % ), seizures ( 50.0% ), fever ( 40.0 % ), cerebral infarction ( 20.0 % ), cerebral venous thrombosis (20.0 % ), multiple focuses of brain (30.0 % ), focus of brain stem and spinal ( 20.0 % ), peripheral nerve disease(10.0%). The highest incidence was headache and seizure. Magnetic resonance imagings of nervous psychopathic SLE were diffuse and focal lesions. Grey and white matters were involved and irregularly distributed. The therapy of hormone can ameliorate the clinical characteristics. Conclusion The clinical manifestations of nervous psychopathic SLE were various. Early diagnosis and prompt therapy are critical to ameliorate the prognosis of nervous psychopathic SLE.
出处 《临床荟萃》 CAS 2012年第15期1302-1305,共4页 Clinical Focus
关键词 狼疮血管炎 中枢神经系统 红斑狼疮 系统性 神经病学表现 磁共振成像 lupus vasculitis,central nervous system lupus erythematosus,systemic neurologic manifestations magnetic resonance imaging
  • 相关文献

参考文献12

  • 1Govoni M,Castellino G,Padovan M,et al. Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus[J]. Lupus, 2004,13(3) : 149-158.
  • 2Anongmous. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes[J]. Arthritis Rheum,1999,42(4):599-608.
  • 3Weder-Cisneros ND, Tellez-Zenteno JF, Cardiel MH, et al. Prevalence and factors associated with headache in patients with systemic lupus erythematosus [ J ]. Cephalalgia, 2004, 24 (12) : 1031-1044.
  • 4Alpa M, Ferrero B, Cavallo R, et al. Anti-GM1 and anti- sulfatide antibodies in patients with systemic lupus erythematosus, Sj6gren' s syndrome, mixed cryoglobulinemia and idiopathic systemic vasculitis[J]. Clin Exp Rheumatol, 2007,25(4) :556-562.
  • 5Denburg SD, Denburg JA. Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus[J]. Lupus,2003,12(12) :883-890.
  • 6Kowal C, DeGiorgio LA, Nakaoka T, et al. Cognition and immunity~ antibody impairs memory[J]. Immunity, 2004, 21 (2) :179-188.
  • 7Weiner SM, Otte A, Uhl M, et al. Neuropsychiatric involvement in systemic lupus erythematosus. Part 2: diagnostic and therapy[J ]. Med Klin ( Munich), 2003,98 (2) : 79-90.
  • 8宾精文,孙玉林,布桂林,杨鸿.系统性红斑狼疮脑病的MRI诊断[J].华西医学,2010,25(7):1286-1288. 被引量:1
  • 9Luyendijk J,Steens SC, Ouwendijk WJ, et al. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging[J]. Arthritis Rheum,2011,63(3) :722 732.
  • 10Chen HC, Lai JH, Juan CJ, et al. Longitudinal myelitis as an initial manifestation of systemic lupus erythematosus[J]. Am J Med Sei,2004,327(2) :105-108.

二级参考文献17

  • 1黄劲柏,徐海波,孔祥泉,刘定西,熊茵,刘刚,王伟,李志勇,郭大静.神经精神性系统性红斑狼疮的磁共振表现[J].实用放射学杂志,2007,23(5):584-586. 被引量:2
  • 2[1]Donadio JV,Glassock RJ .Immunosuppressive drug therapy in lupus nephritis. Ameri J kidney disea,1993;21(3):239
  • 3[2]Bansal VK,Beto JA.Treatment of lupus nephritis:A meta-analysis o f clinical trials. Ameri J Kidney Disea,1997;29(2):193
  • 4[3]Faedda R,Palomba D,Satta A, et al .Immunosuppressive trea tme nt of the glomerulonephritis of systemic lupus .Cninical Nephrology,1995;44(6 ):367
  • 5[4]Balow JE, Boumpas DT,Fessler BJ, et al. Management of lupus nephritis. Kidney international,1996;49(Suppl53):S-88
  • 6[5]Out HJ, Groot PGD, Hasselaar P,et al. Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis,1989;48(12):1023
  • 7[6]Gourley MF, Austin Ⅲ HA, Scott D, et al. Methyl-predniso lone and Cyclophosphamide, Alone or in combination, in patients with lupus nep hrit is. Ann Intern Med,1996;125(7):549
  • 8[7]Conlon PJ, Fischer CA,Levesque MC,et al.Clinical,biochemi cal and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.Clinical Nephrology,1996;46(3) :170
  • 9Mok CC, Mak A, Tsui EY. Shrinking central nervous system in systemic lupus erythematosus[J]. Ann Rheum Dis, 2004,63 (5): 603-604.
  • 10王新得.全身疾病的神经系统表现[M].北京:人民军医出版社,2001:194-196.

共引文献3

同被引文献63

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部